Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.
Sep 15, 2014
0
0
The Food and Drug Administration says it has approved the first generic versions of the blockbuster antidepressant drug Cymbalta, offering lower-cost access to one of the most widely prescribed treatments for depression, ...
Dec 11, 2013
0
0
The Food and Drug Administration is seeking a rule change to allow generic drugmakers to quickly update their warning labels with new safety information for doctors and patients.
Nov 8, 2013
0
0
U.S. drug regulators are publicizing information on brand-name drugmakers that use what government officials call "gaming tactics" to block cheaper copycat versions.
May 17, 2018
0
2
Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drugmakers to include more manufacturers and medications, as well as senior executives at two companies.
Oct 31, 2017
1
0
The Supreme Court says hundreds of out-state-residents can't sue drugmaker Bristol-Myers Squibb Co. in California state court over adverse reactions to the blood thinner Plavix.
Jun 19, 2017
0
0
Critics say the answer pharmaceutical companies are pushing to address the ongoing opioid crisis boosts their profits while forcing taxpayers to shoulder the costs.
Dec 15, 2016
0
0
Federal prosecutors have charged two former pharmaceutical executives with fixing prices of generic drugs, part of an ongoing government investigation into anticompetitive tactics by companies that make lower-cost drugs intended ...
Dec 14, 2016
0
0
Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday.
Oct 7, 2016
0
5
Merck and Sanofi Pasteur are ending their partnership, begun in 1994, to market the drugmakers' vaccines in Europe.
Mar 8, 2016
0
0
